Clinical Scorecard: Challenges in Diagnosis and Histopathological Classification of Idiopathic Multicentric Castleman Disease: A Case Study Involving Multiple Healthcare Facilities

At a Glance

Key Highlights

• iMCD-NOS is often misdiagnosed due to overlapping features with other conditions.
• Excisional biopsy is preferred over core needle biopsy for accurate diagnosis.
• Systematic exclusion of HHV-8 infection and other mimickers is essential.
• Elevated inflammatory markers and systemic symptoms are key diagnostic indicators.
• Multicentric lymphadenopathy requires careful clinical evaluation.

Guideline-Based Recommendations

Diagnosis

• Consider Castleman disease in cases of unexplained lymphadenopathy with systemic symptoms.

Management

• Treatment with siltuximab plus prednisone has shown improvement in symptoms.

Monitoring & Follow-up

• Regular follow-up for symptom resolution and recurrence of lymphadenopathy.

Risks

• Misdiagnosis can lead to unnecessary procedures and delayed treatment.

Patient & Prescribing Data

Adults presenting with persistent lymphadenopathy and systemic inflammatory symptoms.

Combination therapy with siltuximab and prednisone is effective.

Clinical Best Practices

• Utilize excisional biopsy for definitive diagnosis of iMCD-NOS.
• Engage in multidisciplinary collaboration for complex cases.
• Maintain high suspicion for iMCD-NOS in patients with systemic inflammatory symptoms.

Related Resources & Content

• Castleman Disease Overview